A New Medicine to Help Spinal Bones Fuse
Small Molecule Inhibition of Noggin to Induce Spinal Fusion
This research explores a new way to help spinal bones grow together by using a special medicine to reduce side effects often seen with current bone-healing treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11163278 on NIH RePORTER |
What this research studies
Current methods for spinal fusion often use proteins called BMPs to help bones grow, but these can sometimes lead to unwanted side effects like inflammation or nerve irritation. Our project is developing a new small molecule medicine designed to make spinal fusion safer and more effective. This medicine works by blocking a natural protein called noggin, which normally prevents bone growth, allowing lower amounts of bone-healing proteins to be used. The medicine will be delivered directly to the fusion site using a special scaffold, aiming to create a better environment for bones to fuse with fewer complications.
Who could benefit from this research
Good fit: This research is ultimately for patients who need spinal fusion surgery and are looking for options with potentially fewer side effects.
Not a fit: Patients not undergoing spinal fusion or those seeking immediate treatment would not directly benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this approach could lead to safer and more effective spinal fusion surgeries for patients, with fewer side effects than current treatments.
How similar studies have performed: Preliminary studies in animals have shown promising results for this new approach, though the specific small molecule inhibitor is a novel design.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Boden, Scott D. — Emory University
- Study coordinator: Boden, Scott D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.